spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000L

Biotechpharma

Biotechpharma UAB will expand its existing manufacturing facility by adding a new line of bioreactors

Biotechpharma UAB, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced further expansion of its fermentation capacity to 5,000L along with an additional state of the art process development laboratory, investing more than €50 million in the expansion.

Dr. Vladas Bumelis, Chairman of the Board, stated, “The expansion comes amid growing global demand for flexible and responsive outsourcing partners that are able to support the full product lifecycle, from upstream and downstream process development and optimization to GMP manufacturing of drug substance and formulated drug product.” With the new capacity, Biotechpharma continues to advance its mission of becoming a single-source CDMO able to support its worldwide customers with a full range of development and manufacturing services to support clinical and commercial manufacturing.

“We are thrilled to announce this latest expansion of our infrastructure, as it will allow us to better support our customers’ biological development programs with quality, speed and flexibility of service,” said Giedrius Žunda, CEO of Biotechpharma.

The new plant in Europe, located at the company’s site in Vilnius, Lithuania, will contain a new line of bioreactors for microbial fermentation at 5,000L scale and the necessary equipment for downstream processing operations. Flexible facility design will also allow for increased mammalian cell culture production capacities in addition to the already existing two lines of 1000-L and 2000-L for mammalian cell production, both equipped with single use bioreactors. Completion of the plant, which should be operational in Q4 2020, will result in an increase in Biotechpharma’s volume capacity by nearly a factor of two.

“With this latest expansion and plans for continued growth, we are better positioned than ever to meet the growing global demand for these specialized capabilities – and to become a fully integrated biopharmaceutical CDMO.” Said Frank Ternes, CBO of Biotechpharma.

 
About Biotechpharma
Biotechpharma is a contract development and manufacturing organization (CDMO) supporting worldwide customers. Its highly experienced biochemistry, biology and bioprocess engineering staff can deliver projects at any stage, from cell line construction and process development to cGMP production of biopharmaceutical products. High-quality performance and on-time delivery are guaranteed by a team of highly qualified and experienced researchers, engineers, technologists and management professionals. Visit http://www.biotechpharma.lt/

For Further Information Contact:
Phillip Neill
Global Marketing Director
Biotechpharma UAB
+44 7860 785622 (London)
email bd@biotechpharma.lt
web www.biotechpharma.lt
email Mokslininku st. 4. LT-08412 Vilnius, Lithuania
 
Print this page
Send to a friend
   
spacer
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>


White Papers

Contemporary Issues in Comparator Trial Supply

Clinigen CTS

As trial design and execution becomes ever-more complex, initiatives to adapt, increase efficiency and control costs without compromising quality become paramount. Here, Clinigen CTS covers the broad issues and summarises the responses our industry is making in this increasingly demanding landscape.
More info >>

Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement